WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'5501 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 13'8721 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'872  4'805  4'738  4'670  4'601  3'930  3'079  2'348 
Births 74  74  74  73  73  79  83  71 
Surviving infants 73  73  73  73  73  78  82  69 
Pop. less than 5 years 363  361  360  364  367  394  411  319 
Pop. less than 15 years 1'146  1'150  1'156  1'163  1'172  1'236  1'103  881 
Female 15-49 years 1'318  1'306  1'293  1'277  1'260  1'042  774  573 

Number of reported case

(Click for retrospective incidence data for Costa Rica)
Diphtheria
Japanese encephalitis
Measles 76  1'000 
Mumps 30  17  25  419 
Pertussis 58  130  79  71  664  23  75  960 
Polio*
Rubella 86 
Rubella (CRS) 46 
Tetanus (neonatal)
Tetanus (total) 17 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Costa Rica)
Vaccine year result method % card seen                                                
BCG 2010  100  MICS   94  79  78  78  79  81  92  92  80 
DTP1 2010  99  MICS   94  94  92  87  83  91  90 
DTP3 2010  94  MICS   94  95  91  85  91  86  88  95  86 
HepB_BD          90 
HepB3 2010  93  MICS   94  94  91  84  89  87  89 
Hib3 2010  92  MICS   94  95  90  81  93  87  92 
JapEnc         
MCV 2010  97  MICS   94  91  90  83  85  81  82  90  60 
MCV2          92  95  80  79  84 
PCV1          95 
PCV3 2010  93  MICS   94  89  68  97  48 
Pol3 2010  95  MICS   94  95  90  82  96  80  80  95  86 
Rota1         
Rota_last         
Rubella1          91  90  83  83  81 
TT2plus 2010  MICS   94 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Costa Rica)
BCG 79  78  78  77  81  92  92  80 
DTP1 98  92  87  96  91  90  98  95 
DTP3 95  91  85  88  86  88  95  86 
HepB3 94  91  84  89  87  89 
HepB_BD 90  90  88  86  87 
Hib3 95  90  81  90  87  92 
MCV 91  90  83  83  81  82  90  60 
MCV2 92  95  80  79  84 
PCV3 94  89  68  94  48 
Pol3 95  90  82  93  80  80  95  86 
Rota_last

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 79
From 80 to 89% 16
From 50 to 79% 5
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 15 months; Yes
DTaPIPV 4 years; Yes
HepB birth; 2, 6 months; Yes and adults at risk
Influenza > 65 years; Yes and children at risk (6 months) and other at risk groups
MMR 15 months; 6 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Pneumo_ps 65 years; Yes
Rabies When appropriate
Td 10 years; Yes
Tdap pregnant women
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number       2'011       
Nº of districts with microplans that include activities to raise immunization coverage number 103  103    104  104 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  Yes  Yes       

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 77  69  54  70  68  71  34 
% of districts with DTP3 coverage >=80% From 0 to 100% 95  85  67  86  84  88  42 
Nº districts with measles (MCV1) coverage >=95% number 37  37  23  33  29  21   
% of districts with MCV1 coverage >=95% From 0 to 100% 46  46  28  41  36  26   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  19  100 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.